里克托改变在胃肠道瘤中的作用 (综述)
Ruizhen Cao1, Shuilong Guo1, Li Min1
1Department of Gastroenterology, Beijing Friendship Hospital, Capital Medical University, National Clinical Research Center for Digestive Disease, Beijing Digestive Disease Center, Beijing Key Laboratory for Precancerous Lesion of Digestive Disease, Beijing 100050, P.R. China.
里克托是mTORC2信号传输的关键部分,在胃肠道癌症中经常发生变化,并与糟糕的结果有关. 了解Rictor是什么意思
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 胃肠道瘤是癌症死亡的主要原因.
- 哺乳动物目标的拉巴胺素 (mTOR) 信号传输在癌症中经常受到调节.
- 里克托,mTOR复合体2 (mTORC2) 的组成部分,在PI3K/Akt通路中发挥作用,并且在胃肠道瘤中经常发生变化,与化疗耐药性和不良结果相关.
研究的目的:
- 审查瘤中的Rictor突变和生物功能 (细胞增殖,血管新生,细胞亡,自,耐药性).
- 讨论Rictor在结直肠,肝胆,胃,食道,胰腺癌和胆管癌中的特定作用.
- 检查Rictor向疗法的当前和未来前景,重点是抑制Akt激活.
主要方法:
- 文献综述和对Rictor在胃肠道癌症中的现有研究进行批判性讨论.
- 对Rictor参与关键癌症特征的分析.
- 针对Rictor/mTORC2信号的治疗策略的评估.
主要成果:
- 里克托改变在胃肠道瘤中很常见,并且与预后不佳有关.
- 瑞克托影响关键的癌症过程,包括扩散,血管生成,亡,自和耐药性.
- 准Rictor,特别是通过Akt抑制,是一个潜在的治疗途径,尽管机制细节需要进一步阐明.
结论:
- 里克托是胃肠癌发展和进展的重要因素.
- 对Rictor精确机制的进一步研究对于开发有效的向疗法至关重要.
- 了解Rictor是克服胃肠道癌症治疗耐药性的关键.
更多相关视频
07:59Portal Vein Injection of Colorectal Cancer Organoids to Study the Liver Metastasis Stroma
Published on: September 3, 2021
09:29Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
Published on: September 30, 2016
相关概念视频
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The Ras Gene
Ras is a...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
